Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
130.95 USD | -0.49% |
|
-1.01% | +12.87% |
30/06 | Xylem Inc.(NYSE:XYL) dropped from Russell 1000 Dynamic Index | CI |
27/06 | Deutsche Bank Adjusts Price Target on Xylem to $152 From $133, Maintains Buy Rating | MT |
Projected Income Statement: Xylem Inc.
Annual
Quarterly
Annual
Quarterly
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 4,876 | 5,195 | 5,522 | 7,364 | 8,562 | 8,753 | 9,170 | 9,692 |
Change | - | 6.54% | 6.29% | 33.36% | 16.27% | 2.23% | 4.76% | 5.69% |
EBITDA 1 | 776 | 856 | 908 | 1,392 | 1,763 | 1,890 | 2,063 | 2,257 |
Change | - | 10.31% | 6.07% | 53.3% | 26.65% | 7.19% | 9.15% | 9.4% |
EBIT 1 | 525 | 611 | 672 | 1,072 | 1,373 | 1,479 | 1,643 | 1,829 |
Change | - | 16.38% | 9.98% | 59.52% | 28.08% | 7.73% | 11.06% | 11.35% |
Interest Paid 1 | -77 | -76 | -50 | -49 | -44 | -37.76 | -36.96 | -32.32 |
Earnings before Tax (EBT) 1 | 285 | 511 | 440 | 635 | 1,087 | 1,063 | 1,347 | 1,605 |
Change | - | 79.3% | -13.89% | 44.32% | 71.18% | -2.24% | 26.75% | 19.13% |
Net income 1 | 254 | 427 | 355 | 609 | 890 | 879.7 | 1,066 | 1,238 |
Change | - | 68.11% | -16.86% | 71.55% | 46.14% | -1.15% | 21.22% | 16.07% |
Announcement Date | 04/02/21 | 03/02/22 | 07/02/23 | 06/02/24 | 04/02/25 | - | - | - |
1USD in Million
Estimates
Forecast Balance Sheet: Xylem Inc.
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
Net Debt 1 | 1,209 | 1,091 | 936 | 1,265 | 895 | 428 | -355 | -1,228 |
Change | - | -9.76% | -14.21% | 35.15% | -29.25% | -52.18% | -182.94% | -245.92% |
Announcement Date | 04/02/21 | 03/02/22 | 07/02/23 | 06/02/24 | 04/02/25 | - | - | - |
1USD in Million
Estimates
Cash Flow Forecast: Xylem Inc.
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
CAPEX 1 | 183 | 208 | 208 | 271 | 321 | 384 | 405.9 | 413.1 |
Change | - | 13.66% | 0% | 30.29% | 18.45% | 19.64% | 5.68% | 1.8% |
Free Cash Flow (FCF) 1 | 641 | 330 | 388 | 599 | 942 | 817.6 | 1,125 | 1,288 |
Change | - | -48.52% | 17.58% | 54.38% | 57.26% | -13.21% | 37.54% | 14.53% |
Announcement Date | 04/02/21 | 03/02/22 | 07/02/23 | 06/02/24 | 04/02/25 | - | - | - |
1USD in Million
Estimates
Forecast Financial Ratios: Xylem Inc.
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
Profitability | ||||||||
EBITDA Margin (%) | 15.91% | 16.48% | 16.44% | 18.9% | 20.59% | 21.59% | 22.5% | 23.28% |
EBIT Margin (%) | 10.77% | 11.76% | 12.17% | 14.56% | 16.04% | 16.9% | 17.91% | 18.87% |
EBT Margin (%) | 5.84% | 9.84% | 7.97% | 8.62% | 12.7% | 12.14% | 14.69% | 16.56% |
Net margin (%) | 5.21% | 8.22% | 6.43% | 8.27% | 10.39% | 10.05% | 11.63% | 12.77% |
FCF margin (%) | 13.15% | 6.35% | 7.03% | 8.13% | 11% | 9.34% | 12.26% | 13.29% |
FCF / Net Income (%) | 252.36% | 77.28% | 109.3% | 98.36% | 105.84% | 92.93% | 105.45% | 104.05% |
Profitability | ||||||||
ROA | 3.09% | 5.02% | 4.38% | 5.06% | 5.46% | 5.68% | 6.64% | 7.3% |
ROE | 8.57% | 13.81% | 15.38% | 12.08% | 9.8% | 10.38% | 11.11% | 11.67% |
Financial Health | ||||||||
Leverage (Debt/EBITDA) | 1.56x | 1.27x | 1.03x | 0.91x | 0.51x | 0.23x | - | - |
Debt / Free cash flow | 1.89x | 3.31x | 2.41x | 2.11x | 0.95x | 0.52x | - | - |
Capital Intensity | ||||||||
CAPEX / Current Assets (%) | 3.75% | 4% | 3.77% | 3.68% | 3.75% | 4.39% | 4.43% | 4.26% |
CAPEX / EBITDA (%) | 23.58% | 24.3% | 22.91% | 19.47% | 18.21% | 20.32% | 19.68% | 18.31% |
CAPEX / FCF (%) | 28.55% | 63.03% | 53.61% | 45.24% | 34.08% | 46.97% | 36.09% | 32.08% |
Items per share | ||||||||
Cash flow per share 1 | 4.55 | 2.96 | 3.293 | 3.836 | 5.206 | 4.875 | 5.824 | 6.452 |
Change | - | -34.94% | 11.24% | 16.49% | 35.72% | -6.36% | 19.46% | 10.79% |
Dividend per Share 1 | 1.04 | 1.12 | 1.2 | 1.32 | 1.44 | 1.593 | 1.689 | 1.8 |
Change | - | 7.69% | 7.14% | 10% | 9.09% | 10.65% | 5.98% | 6.62% |
Book Value Per Share 1 | 16.45 | 17.84 | 19.38 | 42.08 | 43.79 | 45.93 | 48.11 | 51.25 |
Change | - | 8.43% | 8.65% | 117.08% | 4.08% | 4.88% | 4.75% | 6.51% |
EPS 1 | 1.4 | 2.35 | 1.96 | 2.79 | 3.65 | 3.559 | 4.326 | 5.076 |
Change | - | 67.86% | -16.6% | 42.35% | 30.82% | -2.48% | 21.54% | 17.33% |
Nbr of stocks (in thousands) | 1,80,232 | 1,80,325 | 1,80,222 | 2,41,078 | 2,42,945 | 2,43,351 | 2,43,351 | 2,43,351 |
Announcement Date | 04/02/21 | 03/02/22 | 07/02/23 | 06/02/24 | 04/02/25 | - | - | - |
1USD
Estimates
2025 * | 2026 * | |
---|---|---|
P/E ratio | 36.8x | 30.3x |
PBR | 2.85x | 2.72x |
EV / Sales | 3.69x | 3.44x |
Yield | 1.22% | 1.29% |
More valuation ratios
* Estimated data
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Sell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
130.95USD
Average target price
140.35USD
Spread / Average Target
+7.17%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- XYL Stock
- Financials Xylem Inc.
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition